Atrasentan in Patients with IgA Nephropathy
H
Hiddo J.L. Heerspink
(George Institute for Global Health, University of New South Wales, Sydney)
M
Meg Jardine
(National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney)
D
Donald E. Kohan
(Division of Nephrology, University of Utah Health, Salt Lake City)
R
Richard A. Lafayette
(Stanford University, Stanford, CA)
A
Adeera Levin
A
Adrian Liew
(Mount Elizabeth Novena Hospital, Singapore)
H
Hong Zhang
A
Amit Lodha
(Novartis, East Hanover, NJ)
T
Todd Gray
(Chinook Therapeutics, Seattle)
Y
Yi Wang
R
Ronny Renfurm
(Novartis Pharma, Basel, Switzerland)
J
Jonathan Barratt
Article Details
Journal
New England Journal of Medicine
Volume / Issue
Vol. 392, Issue 6
Published
February 06, 2025
Pages
544-554
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
ISSN: 0028-4793 Social Sciences
Authors (12)
H
Hiddo J.L. Heerspink
George Institute for Global Health, University of New South Wales, Sydney
M
Meg Jardine
National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney
D
Donald E. Kohan
Division of Nephrology, University of Utah Health, Salt Lake City
R
Richard A. Lafayette
Stanford University, Stanford, CA
A
Adeera Levin
A
Adrian Liew
Mount Elizabeth Novena Hospital, Singapore
H
Hong Zhang
A
Amit Lodha
Novartis, East Hanover, NJ
T
Todd Gray
Chinook Therapeutics, Seattle
Y
Yi Wang
R
Ronny Renfurm
Novartis Pharma, Basel, Switzerland
J
Jonathan Barratt
Related Articles from this Journal
Doctor’s Dirty Little Secret — The Cost of Silence
Tara Khan
Aug 2026
10.1056/nejmp2515506
Obstructive Hypertrophic Cardiomyopathy
Julian-Kai Nishizono, Marohito Nakata
Aug 2026
10.1056/nejmicm2603868
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation
Martina Schatzl, Katharina A. Mayer et al.
Jul 2026
10.1056/nejmc2603853
Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
Jerry Avorn
Jul 2026
10.1056/nejmp2604841
Precision Intensification in Metastatic Prostate Cancer
Rana R. McKay
Jul 2026
10.1056/nejme2605582